Invention Grant
US08206711B2 Treatment of chronic lymphocytic leukemia using anti-CD20 antibodies
有权
使用抗CD20抗体治疗慢性淋巴细胞性白血病
- Patent Title: Treatment of chronic lymphocytic leukemia using anti-CD20 antibodies
- Patent Title (中): 使用抗CD20抗体治疗慢性淋巴细胞性白血病
-
Application No.: US12629472Application Date: 2009-12-02
-
Publication No.: US08206711B2Publication Date: 2012-06-26
- Inventor: Christine A. White , Antonio J. Grillo-Lopez , John G. Curd , Susan Desmond-Hellmann
- Applicant: Christine A. White , Antonio J. Grillo-Lopez , John G. Curd , Susan Desmond-Hellmann
- Applicant Address: US MA Cambridge US CA South San Francisco
- Assignee: Biogen Idec Inc.,Genentech, Inc.
- Current Assignee: Biogen Idec Inc.,Genentech, Inc.
- Current Assignee Address: US MA Cambridge US CA South San Francisco
- Agency: Sidley Austin LLP
- Main IPC: A61K39/395
- IPC: A61K39/395 ; A61K51/00
Abstract:
Chronic Lymphocytic Leukemia (CLL) may be treated with antibodies directed against the CD20 antigen.
Public/Granted literature
- US20100080769A1 Treatment of Chronic Lymphocytic Leukemia using Anti-CD20 Antibodies Public/Granted day:2010-04-01
Information query
